Evidence supporting multidisciplinary interventions for frailty in elderly cardiovascular inpatients remains limited. In this completed multicentre, single-blinded, randomised controlled trial (ChiCTR1900022623), 333 frail inpatients aged ≥ 70 years with cardiovascular diseases were randomly assigned to RENAP (Rehabili...
K. Chai, Chen Meng, Li-Wei Ji et al.· Nature Communications· 0 citations
Background: The triglyceride–glucose (TyG) index is recognized as an alternative biomarker of cardiometabolic health, associated with insulin resistance and the development and prognosis of cardiovascular disease (CVD). However, the prospective association between long-term TyG index trajectories and all-cause mortalit...
Chen-Xi Li, Chen-Xi Ouyang, Jie Wang et al.· Reviews in cardiovascular me...· 0 citations
Lp(a) is identified as a genetically informed, clinically relevant biomarker for targeted SCD risk stratification and prevention and is associated with increased SCD risk in older males with elevated TG, with APOE genotypes modulating these effects.
Ying Li, Wei Hong, Yalan Li et al.· Mayo Clinic proceedings· 1 citation
BACKGROUND
Chronic transplant arteriosclerosis is the primary cause of long-term graft failure. Selectively targeting specific inflammatory macrophage subpopulations is essential for inhibiting the primary triggers of inflammatory and immune responses. Therefore, elucidating the origins and regulatory mechanisms of the...
